SIRPA and inflammatory bowel disease: Other subsets of CD172a+ DCs expressing a specific glucosaminoglucan (CD172a+6-sulfo LacNAc DCs) have been observed in higher numbers in the MLNs of patients with CD compared to non-IBD controls, but their exact function in human IBD needs further elucidation [23].